Jean-Louis Misset

The Yield of ¹⁸F-FDG PET/CT in Patients with Clinical Stage IIA, IIB, or IIIA Breast Cancer: A Prospective Study

David Groheux, Sylvie Giacchetti, Marc Espié et al. · Journal of Nuclear Medicine · 2011 · 109 citations · Full text

Medicine, Nuclear Medicine, Oncology +13

18F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer

David Groheux, Elif Hindié, M. Marty et al. · European Journal of Radiology · 2014 · 39 citations

Medicine, Nuclear Medicine, Radiology +14

[Cost/effectiveness analysis of adjuvant therapy with trastuzumab in patients with HER2 positive early breast cancer].

Francis Fagnani, Xavier Colin, Patrick Arveux et al. · PubMed · 2007 · 16 citations

Medicine, Oncology, Pharmacoeconomics +12

From experimental to clinical attempts in immunorestoration with bestatin and zinc

G Mathé, I Blazsek, C Canon et al. · Comparative Immunology Microbiology and Infectious Diseases · 1986 · 14 citations

Life Sciences, Immunology, Pharmacology +6

Prospective study of the impact of using the 21-gene recurrence score assay on clinical decision making in women with estrogen receptor-positive, HER2-negative, early-stage breast cancer in France.

Joseph Gligorov, Xavier Pivot, H. Naman et al. · Journal of Clinical Oncology · 2012 · 12 citations

Medicine, Endocrinology, Oncology +16